Search Results - "Carrega, Maria Eugenia Perez"
-
1
Yellow fever vaccine-associated adverse events following extensive immunization in Argentina
Published in Vaccine (05-03-2014)“…Highlights • We present Argentina's health system experience with YF 17D vaccine AEFI after exceptional use. • Analysis of AEFI was performed through…”
Get full text
Journal Article -
2
Impact of the Single-dose Immunization Strategy Against Hepatitis A in Argentina
Published in The Pediatric infectious disease journal (01-01-2014)“…BACKGROUND:After a country wide outbreak occurred during 2003–2004, 1 dose of hepatitis A vaccine was introduced into Argentinian regular immunization schedule…”
Get full text
Journal Article -
3
Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network
Published in Vaccine (08-01-2018)“…New vaccines designed to prevent diseases endemic in low and middle-income countries are being introduced without prior utilization in countries with robust…”
Get full text
Journal Article -
4
1900. Low Prevalence of Protective Antibodies to Measles Among Young Adults in Argentina
Published in Open forum infectious diseases (26-11-2018)Get full text
Journal Article -
5
Single-Dose Universal Hepatitis A Immunization in 1-Year-Old Infants in Argentina: High Prevalence of Protective Antibodies up to 11 Years Following Vaccination
Published in Open forum infectious diseases (04-10-2017)“…Abstract Background Single-dose Hepatitis A Virus (HAV) vaccination was implemented for all Argentinean children aged 12 months in 2005, instead of the…”
Get full text
Journal Article -
6
Maternal Immunization in Argentina: The Importance of a Safety Profile Analysis
Published in Open forum infectious diseases (01-12-2016)Get full text
Journal Article -
7
Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative
Published in Vaccine (08-01-2018)“…Timely and effective evaluation of vaccine safety signals for newly developed vaccines introduced in low and middle- income countries (LMICs) is essential. The…”
Get full text
Journal Article